Seguir
Nikolai Klebanov
Nikolai Klebanov
Resident at Harvard Dermatology, Massachusetts General Hospital
Dirección de correo verificada de partners.org - Página principal
Título
Citado por
Citado por
Año
Experimental demonstration of a single-molecule electric motor
HL Tierney, CJ Murphy, AD Jewell, AE Baber, EV Iski, HY Khodaverdian, ...
Nature nanotechnology 6 (10), 625-629, 2011
2912011
Focal therapy of neuroblastoma using silk films to deliver kinase and chemotherapeutic agents in vivo
FP Seib, J Coburn, I Konrad, N Klebanov, GT Jones, B Blackwood, ...
Acta biomaterialia 20, 32-38, 2015
552015
Burden of unique and low prevalence somatic mutations correlates with cancer survival
N Klebanov, M Artomov, WB Goggins, E Daly, MJ Daly, H Tsao
Scientific reports 9 (1), 4848, 2019
512019
Dynamic response surface models: a data-driven approach for the analysis of time-varying process outputs
N Klebanov, C Georgakis
Industrial & Engineering Chemistry Research 55 (14), 4022-4034, 2016
442016
Clinical spectrum of cutaneous melanoma morphology
N Klebanov, N Gunasekera, WM Lin, EB Hawryluk, DM Miller, BY Reddy, ...
Journal of the American Academy of Dermatology, 2018
312018
Use of targeted next-generation sequencing to identify activating hot spot mutations in cherry angiomas
N Klebanov, WM Lin, M Artomov, M Shaughnessy, CN Njauw, R Bloom, ...
JAMA dermatology 155 (2), 211-215, 2019
292019
Genetic predisposition to infectious disease
N Klebanov
Cureus 10 (8), 2018
292018
Biocompatibility of a sonicated silk gel for cervical injection during pregnancy: in vivo and in vitro study
AS Critchfield, R Mccabe, N Klebanov, L Richey, S Socrate, ER Norwitz, ...
Reproductive Sciences 21 (10), 1266-1273, 2014
242014
Mechanical and biochemical effects of progesterone on engineered cervical tissue
M House, J Kelly, N Klebanov, K Yoshida, K Myers, DL Kaplan
Tissue Engineering Part A 24 (23-24), 1765-1774, 2018
232018
Growth suppression by dual BRAF (V600E) and NRAS (Q61) oncogene expression is mediated by SPRY4 in melanoma
R Kumar, CN Njauw, BY Reddy, Z Ji, A Rajadurai, N Klebanov, H Tsao
Oncogene 38 (18), 3504-3520, 2019
202019
Melanoma genomics: a state‐of‐the‐art review of practical clinical applications
S Guhan, N Klebanov, H Tsao
British Journal of Dermatology 185 (2), 272-281, 2021
192021
Clinical and therapeutic implications of melanoma genomics
M Shaughnessy, N Klebanov, H Tsao
Journal of Translational Genetics and Genomics 2 (14), 2018
162018
Selective uveal melanoma inhibition with calcium channel blockade
M Shaughnessy, G Lamuraglia, N Klebanov, Z Ji, A Rajadurai, R Kumar, ...
International Journal of Oncology, 2019
152019
Risk of COVID‐19 in patients with cancer receiving immune checkpoint inhibitors
N Klebanov, V Pahalyants, WS Murphy, N Theodosakis, L Zubiri, ...
The Oncologist 26 (5), e898-e901, 2021
142021
Pleomorphic dermal sarcoma of the scalp
N Klebanov, MP Hoang, BY Reddy
Cureus 10 (7), 2018
142018
Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: a retrospective matched cohort study from Massachusetts
V Pahalyants, WS Murphy, N Klebanov, C Lu, N Theodosakis, ...
Journal of the American Academy of Dermatology 86 (1), 252-255, 2022
132022
DRSM Model for the Optimization and Control of Batch Processes
Z Wang, N Klebanov, C Georgakis
IFAC-PapersOnLine 49 (7), 55-60, 2016
112016
A case of nivolumab-induced cutaneous toxicity with multiple morphologies
ED Nguyen, YK Xue, M Danesh, A Ameri, CQ Weng, N Klebanov, ...
Dermatopathology 6 (4), 255-259, 2020
102020
Tuberculous orchitis following intravesical Bacille Calmette-Guérin (BCG) therapy
N Klebanov, A Raghavan
Cureus 10 (5), 2018
62018
Cutaneous presentation of mesothelioma with a sarcomatoid transformation
N Klebanov, BY Reddy, S Husain, DN Silvers, ME Grossman, H Tsao
The American Journal of Dermatopathology 40 (5), 378-382, 2018
62018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20